Trial Profile
A Randomized, Double-Masked, Parallel-Group, Vehicle Controlled, Multicenter, Exploratory Study Assessing the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2020
Price :
$35
*
At a glance
- Drugs Mapracorat (Primary)
- Indications Dry eyes
- Focus Adverse reactions
- Sponsors Bausch & Lomb
- 23 Dec 2014 New trial record